Get early access! Join the Twelve Data AI Assistant waitlist now.

ALNY

454.38000 USD
13.17
2.82%
Last update Aug 22, 3:59 PM EDT
Market closed
Day range
454.20001
469.81000
Previous close
467.54999
Open
469.17001
Access this stock data via API
Subscribe
Alnylam Pharmaceuticals Inc.
454.38
13.17
2.82%

Financials

Income statement

Fiscal date Jun 2025 Mar 2025 Dec 2024 Sep 2024
Total reported revenue 773.7M 594.2M 593.2M 500.9M
Cost of revenue 143.0M 71.0M 102.8M 85.9M
Gross profit 630.7M 523.1M 490.3M 415.0M
Operating expense
Research & development 323.6M 265.1M 300.2M 270.9M
Selling general and admin 323.3M 239.9M 295.3M 221.0M
Other operating expenses
Operating income -16.2M 18.1M -105.2M -76.9M
Non operating interest income
Income 27.5M 28.7M 31.0M 32.1M
Expense 40.2M 38.6M 39.0M 34.4M
Other income expense -6.4M -49.7M -80.8M -29.5M
Pretax income -35.4M -41.6M -194.0M -108.7M
Tax provision 30.9M 15.9M -110.2M 2.9M
Net income -66.3M -57.5M -83.8M -111.6M
Basic EPS -0.4 -0.9
Diluted EPS -0.4 -0.9
Basic average shares 129.7M 128.6M
Diluted average shares 129.7M 128.6M
EBITDA 35.4M 71.3M -84.6M -9.4M
Net income from continuing op. -66.3M -57.5M -83.8M -111.6M
Minority interests
Preferred stock dividends
Market closed

Exchange is currently closed (non-working day)
Pre-market opens in 17 hours 9 minutes

10:50
00:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).